The prevalence of BRCA1/2 mutations was 17.6% (6/34) in women who had DCIS diagnosed before age 50 years, and patients had BRCA2 mutations (5/34, 14.7%) more frequently than BRCA1 mutations (1/34, 2.9%). The gene discussed is BRCA2; the disease is ductal breast carcinoma in situ.